These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32243435)

  • 1. Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening.
    Ndlovu Z; Massaquoi L; Bangwen NE; Batumba JN; Bora RU; Mbuaya J; Nzadi R; Ntabugi N; Kisaka P; Manciya G; Moudashirou R; Pangani H; Mangochi P; Makoko R; Van Laeken D; Kwitonda C; Ronoh Y; Kuwenyi K; Ortuno R; Mangwanya D; Zvidzai E; Mupepe T; Zinyowera S; Fajardo E; Ellman T
    PLoS One; 2020; 15(4):e0230453. PubMed ID: 32243435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant Women.
    Luchters S; Technau K; Mohamed Y; Chersich MF; Agius PA; Pham MD; Garcia ML; Forbes J; Shepherd A; Coovadia A; Crowe SM; Anderson DA
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance characteristics of an instrument-free point-of-care CD4 test (VISITECT®CD4) for use in resource-limited settings.
    Vidhyavathi V; Iqbal HS; Kanthamani K; Solomon SS; Nandagopal P; Luchters S; Pham MD; Forbes J; Crowe SM; McMurran C; Anderson DA; Balakrishnan P
    J Int Med Res; 2020 Sep; 48(9):300060520955028. PubMed ID: 32985310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory Evaluation of the VISITECT Advanced Disease Semiquantitative Point-of-Care CD4 Test.
    Lechiile K; Leeme TB; Tenforde MW; Bapabi M; Magwenzi J; Maithamako O; Mulenga F; Mohammed T; Ngidi J; Mokomane M; Lawrence DS; Mine M; Jarvis JN
    J Acquir Immune Defic Syndr; 2022 Dec; 91(5):502-507. PubMed ID: 36084198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A profile of the Visitect® CD4 and Visitect® CD4 advanced disease for management of people living with HIV.
    Pham MD; Stoove M; Crowe S; Luchters S; Anderson D
    Expert Rev Mol Diagn; 2022 Mar; 22(3):247-252. PubMed ID: 35226590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation.
    Gils T; Kamele M; Madonsela T; Bosman S; Ngubane T; Joseph P; Reither K; Bresser M; Vlieghe E; Decroo T; Ayakaka I; Lynen L; Van Heerden A
    PLoS One; 2023; 18(12):e0296197. PubMed ID: 38134020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.
    Boyd K; Kouamou V; Hlupeni A; Tangwena Z; Ndhlovu CE; Makadzange AT;
    Microbiol Spectr; 2022 Aug; 10(4):e0107522. PubMed ID: 35924841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective evaluation of the diagnostic accuracy of the point-of-care VISITECT CD4 Advanced Disease test in seven countries.
    Gils T; Hella J; Jacobs BKM; Sossen B; Mukoka M; Muyoyeta M; Nakabugo E; Van Nguyen H; Ubolyam S; Macé A; Vermeulen M; Nyangu S; Sanjase N; Sasamalo M; Dinh HT; Ngo TA; Manosuthi W; Jirajariyavej S; Denkinger CM; Nguyen NV; Avihingsanon A; Nakiyingi L; Székely R; Kerkhoff AD; MacPherson P; Meintjes G; Reither K; Ruhwald M
    J Infect Dis; 2024 Jul; ():. PubMed ID: 39046150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced HIV disease: A review of diagnostic and prophylactic strategies.
    Lehman A; Ellis J; Nalintya E; Bahr NC; Loyse A; Rajasingham R
    HIV Med; 2023 Aug; 24(8):859-876. PubMed ID: 37041113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the BD FACSPresto near to patient analyzer in comparison with representative conventional CD4 instruments in Cameroon.
    Sagnia B; Mbakop Ghomsi F; Gutierrez A; Sosso S; Kamgaing R; Nanfack AJ; Nji N; Ambada G; Lissom A; Tchouangueu TF; Ngu Ndengkoh L; Domkam I; Nchinda G; Ndjolo A
    AIDS Res Ther; 2020 Aug; 17(1):53. PubMed ID: 32799909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4.
    Diaw PA; Daneau G; Coly AA; Ndiaye BP; Wade D; Camara M; Mboup S; Kestens L; Dieye TN
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):e103-11. PubMed ID: 21909029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic performance of the Visitect Advanced Disease point-of-care CD4 platform: a pragmatic mixed-methods multisite validation, costing, and qualitative analysis.
    Nalintya E; Sekar P; Namakula OL; Tadeo KK; Kwizera R; Apeduno L; Naluyima DR; Nanano R; Mujungu L; Lehman A; Adzemovic T; Amperiize M; Kavuma P; Kasone V; Fieberg A; Nerima P; Dai B; Meya DB; Boulware DR; Rajasingham R
    J Acquir Immune Defic Syndr; 2024 Aug; ():. PubMed ID: 39159398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care CD4+ technology implementation in Free State, South Africa, was associated with improved patient health outcomes.
    Van Turha L; Maharaj K; Rose A; Boeke C; Peter TF; Vojnov L; Quevedo J; Tsibolane Y
    S Afr Med J; 2020 Jan; 110(2):126-131. PubMed ID: 32657683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.
    Negedu-Momoh OR; Jegede FE; Yakubu A; Balogun O; Abdullahi M; Badru T; Oladele EA; Agbakwuru C; Khamofu H; Torpey K
    PLoS One; 2017; 12(5):e0178037. PubMed ID: 28542359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
    Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
    PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative assessment of South African healthcare worker perspectives on an instrument-free rapid CD4 test.
    Scorgie F; Mohamed Y; Anderson D; Crowe SM; Luchters S; Chersich MF
    BMC Health Serv Res; 2019 Feb; 19(1):123. PubMed ID: 30764808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya.
    Zeh C; Rose CE; Inzaule S; Desai MA; Otieno F; Humwa F; Akoth B; Omolo P; Chen RT; Kebede Y; Samandari T
    J Immunol Methods; 2017 Sep; 448():44-50. PubMed ID: 28529048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the BD-FACS Presto for CD4 count and hemoglobin measurement in a district hospital and rural laboratory in Ghana.
    Moran Z; Sacks JA; Frimpong FK; Frimpong AB; Ben Amor Y
    PLoS One; 2019; 14(2):e0212684. PubMed ID: 30794637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid point-of-care CD4 testing at mobile units and linkage to HIV care: an evaluation of community-based mobile HIV testing services in South Africa.
    Sloot R; Glenshaw MT; van Niekerk M; Meehan SA
    BMC Public Health; 2020 Apr; 20(1):528. PubMed ID: 32306930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.
    Myer L; Daskilewicz K; McIntyre J; Bekker LG
    J Int AIDS Soc; 2013 Sep; 16(1):18649. PubMed ID: 24044627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.